UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. A Phase 3, Randomized, Double-Blind, Multicenter Study Comparing Oral MLN9708 Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagno…
    Guido Tricot
  2. Impact of Donor Statin Use on GVHD after Unrelated Donor Hematopoietic Cell Transplantation
    Margarida Magalhaes-Silverman
  3. A Follow-Up Study of Addictions and Co-Occurring Disorders
    Donald Black
  4. Preterm Infant Run-In/Interim Study
    Peggy Nopoulos
  5. Cupid 2b: Enzyme Replacement Therapy for Advanced Heart Failure
    Frances Johnson
  6. Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma
    Mohammed Milhem
  7. Targeting Inflammation to Treat Cardiovascular Aging in Humans
    Gary L. Pierce
  8. Adolescent Brain Development - No History
    Daniel O'Leary
  9. A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase 3 Study of the Safety, Tolerability, and Efficacy of CMX001 for the Prevention of Cytomegalovirus (CMV) Infection in…
    Jeffery Meier
  10. Neuropsychological, Social Emotional, and Behavioral Outcomes in Children with Cancer
    Ayman El-Sheikh
  11. Interagency Registry of Mechanically Assisted Circulatory Support (INTERMACS)
    Jennifer Goerbig-Campbell
  12. A Trial of Intensive Multi-Modality Therapy for Extra-Ocular Retinoblastoma
    Ayman El-Sheikh
  13. A Multicenter, Open-Label Single-Arm Study of YONDELIS (trabectedin) for Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma ...
    Mohammed Milhem
  14. [F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers
    Sarah McGuire
  15. A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction (LEPHT)
    KellyAnn Light-McGroary
  16. High-Frequency OAEs and Ototoxicity
    Shawn Goodman
  17. SynCardia CardioWest TAH-t Postmarket Surveillance Study
    Jennifer Goerbig-Campbell
  18. RTOG 1010: A phase III trial evaluating the addition of trastuzumab to trimodality treatment of HER2-overexpressing esophageal adenocarinoma
    Mark C. Smith
  19. A randomized double-blinded phase III study comparing gemcitabine, cisplatin, and bevacizumab (IND #7921, NSC #704865) to gemcitabine, cisplatin, and placebo in patients with advanced transitional cel…
    Daniel Vaena
  20. A randomized double-blind, placebo-controlled study of LEE011 in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive, HER2-negative, advanced breast can…
    Alexandra Thomas

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.